A series of 45 patients (31 female) underwent clam enterocystoplasty for urgency and incontinence. The majority had detrusor instability. Prolonged conservative treatment had failed in all cases. Improvement occurred in 71% and those younger than 30 years had better overall results; 29% remained incontinent, with 9% requiring a urinary diversion. Many patients did not achieve maximum benefit until 9 months post-operatively. Surgery had no statistically significant effect on any urodynamic parameter and post-operative complications were common. The operation was performed in either the coronal (19) or the sagittal plane (26); this did not influence results. In general, surgery was found to be technically simpler in the sagittal group and it is recommended that this becomes the standard procedure. We feel that this operation involves major surgery and should only be offered with reluctance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1464-410x.1991.tb15253.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-term results of clam enterocystoplasty in non-neurogenic refractory urge incontinence.
Urologia
February 2024
Department of Urology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey.
Objectives: This study aims to assess the efficacy of Clam enterocystoplasty (CECP) surgery for the treatment of non-neurogenic refractory urgency urinary incontinence (UUI).
Methods: We conducted a retrospective evaluation of 17 female patients who underwent CECP for non-neurogenic refractory UUI between May 2010 and November 2022.
Results: The median of ICIQ-SF was 19 (15-21) before treatment, which decreased to a median of 0 (0-5) after treatment ( = 0.
Clam augmentation enterocystoplasty as management of urge urinary incontinence and reduced bladder capacity.
Scand J Urol
December 2019
Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
Third line treatment of urge urinary incontinence (UUI) and/or reduced bladder capacity is bladder augmentation. The aim of this study was to investigate whether clam enterocystoplasty (CECP) was an efficient treatment for patients who were refractory to conservative treatments of UUI and small functional bladder capacity and secondly if there was a difference in outcome in patients with neurogenic and non-neurogenic bladders. We evaluated 118 patients retrospectively treated in the period 2006-2018 at a single university hospital.
View Article and Find Full Text PDFDetrusor myectomy: long-term functional outcomes.
Int J Urol
December 2012
Department of Urology, University Hospital of Wales, Cardiff, UK.
Objectives: Detrusor myectomy is a recognized method of bladder augmentation for treating refractory detrusor overactivity. Herein we report the long-term outcomes of this procedure at the University Hospital of Wales in Cardiff, UK.
Methods: Detrusor myectomy was carried out in 33 patients (7 males, 26 females) with urodynamically proven detrusor overactivity between 1995 and 2002.
Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients.
World J Urol
February 2009
Department of Urology, Keck School of Medicine, University of Southern California, Rancho Los Amigos National Rehabilitation Center, Los Angeles, California, USA.
Objectives: Augmentation enterocystoplasty is the standard treatment for patients with neurogenic bladder who have failed medical management. Our "extraperitoneal" approach involves a small peritoneotomy to obtain the segment of bowel for augmentation, and a standard "clam" enterocystoplasty. We compared operative and postoperative parameters and clinical outcomes of this technique with the standard intraperitoneal technique.
View Article and Find Full Text PDFIdentification of early p53 mutations in clam ileocystoplasties using restriction site mutation assay.
Urology
November 2007
Department of Urology, University Hospital of Wales, Cardiff, United Kingdom.
Objectives: Because a risk of cancer arising in enterocystoplasties exists, it is necessary to identify which patients are most at risk of tumor formation. The aim of this study was to determine whether rare mutated p53 sequences were more common at the enterovesical anastomosis than in the bladder remnant in patients with a clam ileocystoplasty using the restriction site mutation (RSM) assay.
Methods: DNA was extracted from endoscopic biopsies obtained from the ileovesical anastomosis and native bladder remnant (control specimens) of 38 patients with a clam ileocystoplasty.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!